IAIN GALLEGO: Open Payments
NPI 1720198674 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,752 in 146 payments from 27 companies in 2025. Trend: 2023 $3,275 · 2024 $3,036 · 2025 $3,752
Food & beverage: $3,752
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $649 |
| Amgen Inc. | 7 | $403 |
| Lilly USA, LLC | 22 | $377 |
| Novo Nordisk Inc | 16 | $292 |
| AstraZeneca Pharmaceuticals LP | 11 | $246 |
| PFIZER INC. | 6 | $182 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $161 |
| GlaxoSmithKline, LLC. | 8 | $161 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $136 |
| E.R. Squibb & Sons, L.L.C. | 2 | $135 |
Products named: VRAYLAR, MOUNJARO, KRYSTEXXA, JARDIANCE, Wegovy, ISTURISA, UBRELVY, CAMZYOS.
Industry payments across CA — which companies pay providers there.
